Cognitive deficits are highly prevalent in alcohol-dependent (AD) patients and may have a detrimental impact on treatment response and treatment outcome. Enhancing cognitive functions may improve treatment success. Modafinil is a promising compound in this respect. Therefore, a randomized double-blind placebo-controlled trial was conducted with modafinil (300 mg/d) or placebo in 83 AD patients for 10 weeks. Various cognitive functions (digit span task, Tower of London task, Stroop task) were measured at baseline, during and after treatment. Compared to placebo, modafinil improved verbal short-term memory (number of forward digit spans) (p=0.030), but modafinil exerted a negative effect on the working memory score of the digit span task (p=0.003). However, subgroup analyses revealed that modafinil did improve both working memory and verbal short-term memory in AD patients with a poor working memory ability at baseline (25% worst performers), whereas no significant treatment effect of modafinil was found on these two dependent variables in patients with good working memory skills at baseline (25% best performers). No effect of modafinil was found on measures of planning (Tower of London task) and selective attention (Stroop task). Further research is needed to better understand the relationship between cognitive remediation and treatment outcome in order to design targeted treatments.
AlfonsoJPCaracuelADelgado-PastorLC, et al. (2011) Combined goal management training and mindfulness meditation improve executive functions and decision-making performance in abstinent polysubstance abusers. Drug Alcohol Depend117: 78–81.
2.
BartelsCKunertHJStawickiS, et al. (2007) Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol Alcohol42: 92–102.
3.
BatesMEBowdenSCBarryD (2002) Neurocognitive impairment associated with alcohol use disorders: Implications for treatment. Exp Clin Psychopharmacol10: 193–212.
4.
BatesMEVoelbelGTBuckmanJF, et al. (2005) Short-term neuropsychological recovery in clients with substance use disorders. Alcohol Clin Exp Res29: 367–377.
5.
BlumeAWSchmalingKBMarlattGA (2005) Memory, executive cognitive function, and readiness to change drinking behavior. Addict Behav30: 301–314.
6.
BradyKTGrayKMTolliverBK (2011) Cognitive enhancers in the treatment of substance use disorders: Clinical evidence. Pharmacol Biochem Behav99: 285–294.
CoolsR (2008) Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist14: 381–395.
9.
CoolsRD’EspositoM (2011) Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry69: e113–e125.
10.
CoxWMFadardiJSPothosEM (2006) The Addiction-Stroop Test: Theoretical considerations and procedural recommendations. Psychol Bull132: 443–476.
11.
DackisCAKampmanKMLynchKG, et al. (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology30: 205–211.
12.
DeanACSevakRJMonterossoJR, et al. (2011) Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs72: 943–953.
13.
DeBattistaCLembkeASolvasonHB, et al. (2004) A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol24: 87–90.
14.
EagleDMTufftMRAGoodchildHL, et al. (2007) Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl)192: 193–206.
15.
Fernández-SerranoMJPérez-GarcíMVerdejo-GarcíaA (2011) What are the specific vs generalized effects of drugs of abuse on neuropsychological performance?Neurosci Biobehav Rev35: 377–406.
16.
FinkeKDoddsCMBublakP, et al. (2010) Effects of modafinil and methylphenidate on visual attention capacity: A TVA-based study. Psychopharmacology (Berl)210: 317–329.
17.
FitzmauriceGLairdNWareJ (2004) Applied Longitudinal Analysis. New York: John Wiley and Sons.
18.
GossopMKeaneyFStewartD, et al. (2002) A Short Alcohol Withdrawal Scale (SAWS): Development and psychometric properties. Addict Biol7: 37–43.
19.
GoudriaanAEOosterlaanJde BeursE, et al. (2006) Neurocognitive functions in pathological gambling: A comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction101: 534–547.
20.
HeinzerlingKGSwansonA-NKimS, et al. (2010) Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend109: 20–29.
21.
HendriksVMKaplanCDVanlimbeekJ, et al. (1989) The addiction severity index: Reliability and validity in a Dutch addict population. J Subst Abuse Treat6: 133–141.
22.
HoubenKWiersRWJansenA (2011) Getting a grip on drinking behavior: Training working memory to reduce alcohol abuse. Psychol Sci22: 968–975.
23.
JoosLDocxLSchmaalL, et al. (2010) Modafinil in psychiatric disorders: The promising state reconsidered. Tijdschr Psychiatr52: 763–773.
24.
JoosLGoudriaanAESchmaalL, et al. (2013) Effect of modafinil on impulsivity and relapse in alcohol dependent patients: A randomized, placebo-controlled trial. Eur Neuropsychopharmacol23: 948–955.
25.
KalechsteinADDelaGarzaR2nd and NewtonTF (2010) Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. Am J Addict19: 340–344.
26.
KoperaMWojnarMBrowerK, et al. (2012) Cognitive functions in abstinent alcohol-dependent patients. Alcohol46: 665–671.
27.
LemmensPH (1994) The alcohol content of self-report and ‘standard’ drinks. Addiction89: 593–601.
28.
ManningVWanigaratneSBestD, et al. (2008). Changes in neuropsychological functioning during alcohol detoxification. Eur Addict Res14: 226–233.
29.
MinzenbergMJCarterCS (2008) Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology33: 1477–1502.
30.
MoselhyHFGeorgiouGKahnA (2001) Frontal lobe changes in alcoholism: A review of the literature. Alcohol Alcohol36: 357–368.
31.
RandallDCViswanathABharaniaP, et al. (2005) Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?J Clin Psychopharmacol25: 175–179.
32.
RuppCIKemmlerGKurzM, et al. (2012) Cognitive remediation therapy during treatment for alcohol dependence. J Stud Alcohol Drugs73: 625–634.
33.
SaletuBSaletuMGrünbergerJ, et al. (1990) On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies. Prog Neuropsychopharmacol Biol Psychiatry14: 195–214.
34.
SchmaalLJoosLKoelemanM, et al. (2013) Effects of Modafinil on Neural Correlates of Response Inhibition in Alcohol-Dependent Patients. Biol Psychiatry73: 211–218.
35.
SchmandBLindeboomJVan HarskampF (1992) NLV: Nederlandse Leestest Voor Volwassenen: Handleiding. Lisse: Swets & Zeitlinger.
36.
SobellLCSobellMB (1992) Timeline follow-back: A technique for assessing self-reported alcohol consumption. In: LittenRZAllenJP (eds) Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Totowa, New Jersey: Humana Press, pp. 41–72.
37.
SpenceSAGreenRDWilkinsonID, et al. (2005) Modafinil modulates anterior cingulate function in chronic schizophrenia. Br J Psychiatry187: 55–61.
38.
SunXZhangXChenX, et al. (2005) Age-dependent brain activation during forward and backward digit recall revealed by fMRI. Neuroimage26 : 36–47.
39.
SwansonJMGreenhillLLLopezFA, et al. (2006) Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: Results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry67: 137–147.
40.
TedstoneDCoyleK (2004) Cognitive impairments in sober alcoholics: Performance on selective and divided attention tasks. Drug Alcohol Depend75: 277–286.
41.
TeichnerGHornerMDHarveyRT (2001) Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. Int J Neurosci106: 253–263.
42.
TurnerDCClarkLDowsonJ, et al. (2004a) Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry55: 1031–1040.
43.
TurnerDCClarkLPomarol-ClotetE, et al. (2004b) Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology29: 1363–1373.
44.
TurnerDCRobbinsTWClarkL, et al. (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl)165: 260–269.
45.
Van den HeuvelOAGroenwegenHJBarkhofF, et al. (2003) Frontostriatal system in planning complexity: A parametric functional magnetic resonance version of Tower of London task. Neuroimage18: 367–374.
46.
Van HolstRJSchiltT (2011) Drug-related decrease in neuropsychological functions of abstinent drug users. Curr Drug Abuse Rev4: 42–56.
47.
Van VlietIMDe BeursE (2007) The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders. Tijdschr Psychiatr49: 393–397.
48.
VolkowNDFowlerJSLoganJ, et al. (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. JAMA301: 1148–1154.
49.
WechslerD (1997) WAIS-III Administration and Scoring Manual. San Antonio, Texas: Psychological Corporation.
50.
WölwerWBurtscheidtWRednerC, et al. (2001) Out-patient behaviour therapy in alcoholism: Impact of personality disorders and cognitive impairments. Acta Psychiatr Scand103: 30–37.
51.
ZackMPoulosCX (2009) Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs low impulsivity. J Psychopharmacol23: 660–671.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
